Memory boost? study tests 'Test Yourself' method in schizophrenia
NCT ID NCT02150174
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a memory technique called 'retrieval practice' works in people with schizophrenia. Participants studied word pairs and were later tested or re-studied them. The goal was to see if testing improves recall more than re-studying. 40 people took part, including healthy controls, to compare results.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If effective, this method could be used in cognitive remediation programs to help people with schizophrenia improve their memory.
- What could go wrong
- This is a small, early exploratory study with only 40 participants. It does not test a treatment, only a learning technique, so results may not lead to practical benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Jul 2014
- Finished
-
Aug 2015
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * French is the native language, or acquired before 5 years old * People must be able to understand and follow the trial instructions Specific inclusion criteria (for patients) : * Diagnostic of schizophrenia, according to the DSM -5, clinically stable * The treatment must remain unchanged during the trial Exclusion Criteria: * Severe or acute cerebral disease * Other actual psychiatric disorder * Use of drugs with high anticholinergic effect * Irregular use of benzodiazepines medication, or high dose of benzodiazepin (more than 2 mg of lorazepam per day or equivalent) * Inappropriate use of drugs Specific exclusion criteria (for healthy subjects) : \- Diagnostic of schizophrenia of a relative up to the third degree
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Episodic memory deficits are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Psychothérapique de Nancy
Laxou, 54521, France
-
Service de psychiatrie - Hôpital Civil - CHRU Strasbourg
Strasbourg, 67091 Cedex, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may reveal if You're taking your psychiatric medication
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug